YW3-02 Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer (Young Urologist Research Workshop)

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本泌尿器科学会の論文
• 2004-03-15

著者

• Kubo Hiroyuki

  Department Of Biology Faculty Of Science Shinshu University

• Kubo Hiroyuki

  Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University

関連論文

• Detection and Characterization of a Vacuolar Protein(VP24) in Anthocyanin Producing Cells of Sweet Potato in Suspension Culture : PROTEINS, ENZYMES AND METABOLISM : STRUCTURE AND FUNCTION OF CELLS
• Evaluation of Bile Acids and Fusidate Derivative as Nasal Absorption Enhancers Using an Electrophysiological Technique
• Reversal of P-Glycoprotein-mediated Paclitaxel Resistance by New Synthetic Isoprenoids in Human Bladder Cancer Cell Line
• Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer
• Primary malignant melanoma of the male urethra
• Lack of photophobia associated with bilateral ventral occipital lesion
• YW3-02 Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer (Young Urologist Research Workshop)

スポンサーリンク